Image Credit: STAT News
Opinion: STAT+: Impatient about cell and gene therapy? Progress in biotech is not always linear
The arc of biotechnology is one of breakthroughs and struggles, writes Tim Hunt, CEO of the Alliance for Regenerative Medicine.